Skip to main content

Qiming Venture Partners — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

399
Companies
$14.9B
Total invested
$60.5M
Avg. check
48
Industries
Medical 10Biotechnology 8Health Care 8Biopharma 4Cryptocurrency 3Pharmaceutical 3+42 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 399
Matrixport
January 2023

Matrixport is a digital assets financial services platform where users can invest, trade, and leverage crypto assets.

Cryptocurrency · Singapore$38.0M Series C
LetsGetChecked
January 2025

LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.

Biotechnology · Atlanta$165.0M Series F
Structure Therapeutics
December 2025

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Biotechnology · South San Francisco$747.5M Post-IPO Equity
Sanegene Bio
December 2025

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Biopharma · Woburn$110.0M Series B
Rhino Federated Computing
January 2026

The revolutionary platform for decentralized AI collaborations - unlock data silos without data sharing.

Artificial Intelligence (AI) · Boston$11.3M Series A
Sinogen Biopharma
December 2023

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Biopharma · BostonSeries B
Veridise
December 2022

Veridise is a leader in blockchain security. The company offers Web3 security audits of ZKP, DeFi, Layer 1 & Layer 2s, dApps, and more.

Blockchain · AustinSeries A
Wholee
December 2021

Wholee is a member-only zero-markup store.

E-Commerce · Woodlands$69.0M Series B
Green Energy Origin
December 2025

Green Energy Origin is a sustainable firm that develops specialty chemicals and battery raw materials for cost effective energy solutions.

GreenTech · Weinheim$110.0M Series B
Platelet BioGenesis
November 2021

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Biotechnology · Watertown$75.5M Series B
Caidya
January 2025

Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.

Biotechnology · Raleigh$165.0M Private Equity
ZSHK Laboratories
November 2022

ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.

Biopharma · Wan Chai$12.5M Series B
Tupos Therapeutics
November 2024

The company is currently operating in Stealth Mode.

Oakland$41.0M Seed
BIT
January 2023

BIT provides digital asset financial infrastructure and services to institutional and professional investors globally.

Cryptocurrency · Singapore$38.0M Series C
ZEGOCLOUD
January 2022

Video, Voice & Chat API for Real-Time Interaction and Real-Time Communication.

Artificial Intelligence (AI) · Singapore$102.0M Series D
Alamar Biosciences
January 2026

Powering precision proteomics to enable to the earliest detection of disease.

Biotechnology · Fremont$50.0M Convertible Note
Atom Semiconductor
November 2021

Atom Semiconductor is a scientific and technological enterprise focusing on digital sensor design.

Electronics · Hong Kong$15.7M Seed
Cornerstone Robotics
November 2025

Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.

Health Care · Hong Kong$200.0M Venture - Series Unknown
Kezar Life Sciences
October 2022

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Health Care · South San Francisco$12.2M Post-IPO Equity
CODE 27
March 2026

CODE 27 develops software solutions focused on digital platforms, data systems, and custom technology applications.

Developer Platform · San Francisco$10.0M Angel
Video Rebirth
March 2026

Video Rebirth is a private limited company that is established with shares.

Singapore$30.0M Series Unknown
Tianhu Technology
March 2026

Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.

Alternative Protein · Minhang$29.0M Series A
Stairway Medical
March 2026

Stairway Medical is a developer of implantable brain-computer interface technology.

Health Care · Pudong$72.6M Series Unknown
CSR Biotech
March 2026

CSR Biotech is a biological research company that provides cell imaging and data processing services.

Biopharma · HaidianSeries B

Where Qiming Venture Partners invests

Medical10
Biotechnology8
Health Care8
Biopharma4
Cryptocurrency3
Pharmaceutical3

About Qiming Venture Partners's portfolio

How many companies has Qiming Venture Partners invested in?▸

Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Qiming Venture Partners invest in?▸

Qiming Venture Partners's top investment sectors include Medical, Biotechnology, Health Care, Biopharma, Cryptocurrency. The firm invests across 48 different industry categories.

What is Qiming Venture Partners's largest investment?▸

Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post-IPO Equity round. Qiming Venture Partners's total known invested capital is $14.9B.

What is the average investment size for Qiming Venture Partners?▸

Qiming Venture Partners's average investment size is $60.5M across its portfolio of 399 companies.

What are Qiming Venture Partners's most recent investments?▸

Recent Qiming Venture Partners portfolio additions include Matrixport, LetsGetChecked, Structure Therapeutics, Sanegene Bio, Rhino Federated Computing. These companies were founded in 2020 or later.

Reach the founders behind these 399 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →